Health ❯ Nutrition ❯ Weight Management

Obesity

Weight Loss Medications Weight Loss Drugs Health Risks Lifestyle Changes GLP-1 Drugs Weight-loss Medications Drug Treatments Body Mass Index Physical Activity Treatment Options Visceral Fat GLP-1 Medications GLP-1 Receptor Agonists Gastric Band Surgery Dietary Strategies Weight Loss Diabetes Management Anti-Obesity Medications Epigenetics Impact on Joint Health Hormonal Effects Healthy Lifestyle Eating Disorders Clinical Trials GLP-1 Medication BMI Criteria BMI Calculation Breast Cancer Weight-Loss Treatments Sleep Deprivation Health Outcomes Pharmacotherapy Fat-Free Mass Health Claims Drug Impact on Muscle Menopause Dietary Habits Drug Efficacy Heart Health Weight Loss Treatments Polycystic Ovary Syndrome Lean Body Mass Body Composition Metabolic Health Cognitive Decline Diabetes Cholesterol Levels Wegovy Adult Weight Gain Weight-Loss Surgery Weight-Loss Drugs Diet Industry Child Health Health Conditions Semaglutide Fettzellen Reality TV Effects Cardiometabolic Health Impact on Mental Health GLP-1 Hormone Pharmaceutical Treatments Weight Loss Injections BMI Standards Weight Loss Strategies Pharmaceutical Interventions Weight Loss Challenges Health Implications Public Perception Oral Medications Yo-Yo Effect Medications for Obesity Weight Gain Food Noise Medication Weight-loss Drugs

Large Penn Study Finds GLP‑1 Use Tied to Lower Breast Cancer Rates

Researchers say the observational link points to metabolic and possible direct effects but call for randomized trials before changing care

Early Evidence Suggests GLP‑1 Weight Drugs Can Raise Testosterone and Improve Sperm in Men With Obesity

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

Study Finds 8,500 Daily Steps Help People Keep Weight Off After Dieting

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Oprah Winfrey Recounts Joan Rivers’ 1985 On‑Air Body‑Shaming, Connecting It to a New Health Push

Oprah Winfrey Recasts Obesity as Disease in New Book, Backs GLP-1s as Long-Term Care

Oxford Review Finds GLP-1 Weight Loss Largely Lost Within About Two Years After Stopping

Oprah Credits GLP-1s With Ending Alcohol Cravings, Plans Lifelong Use

Hims & Hers in Talks With Novo Nordisk on Wegovy After Q3 Revenue Beat

Lancet Analysis: Semaglutide Cuts Major Heart Events Regardless of Weight Loss

Weight Swings in Older Adults Linked to Faster Cognitive Decline, Study Finds

Mouse Study Finds Ozempic Reduces Lean Mass and Shrinks Organs

GLP-1 Weight-Loss Drugs Fail to Boost Fitness and Cause Significant Muscle Loss